Peter MacCallum Cancer Centre
CellVec enters strategic partnership with Peter MacCallum Cancer Centre
CellVec enters strategic partnership with Peter MacCallum Cancer Centre
The partnership will enable high-potential research on cancer immunotherapy in Asia Pacific.
Most Read
1. Asian medical device markets face cost shocks amidst Iran conflict 2. Gene and cell therapy boom drives DNA manufacturing market toward $21.82B by 2034 3. Global dental articulators market to reach $227.8m by 2030 4. Neurological disorders and aging boost brain-computer interface market 5. HSA to expand role in accelerating biomedical sector growth: Ong Ye KungResource Center
Read Here
Advertise
Sign Up
Events
Event News
He discusses how healthcare systems in Asia Pacific need to evolve beyond simply expanding coverage and towards delivering equitable, sustainable, and high-impact care.
Commentary
Beyond ChatGPT: The rise of multimodal AI assistants in clinical settings
2026 biotech playbook: Hong Kong at the centre of China’s globalisation